Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Idenix Pharmaceuticals, Inc.

Idenix Pharmaceuticals shares plunged 19.78 percent on volume of nearly 6 million shares traded Monday to close at $3.69 a share. The company announced that the U.S. Patent and Trademark Office Patent Trial and Appeal Board has decided against the company in the first phase of the ongoing interference concerning one of the Company’s patent applications and an issued patent owned by Gilead Pharmasset LLC.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on